Kenichiro Sato

14PUBLICATIONS
7CO-AUTHORS
Stochastic analysis and modellingComputational linguisticsClinical chemistry (incl. diagnostics)Archaeology of Asia, Africa and the AmericasClimate change impacts and adaptation not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 21, 2026
Projected lecanemab wastage from vial discard: Simulation based on Japanese interim post-marketing surveillance summary statistics.

|Jun 27, 2026
Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies.

|Apr 21, 2026
Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database.

|Jan 15, 2026
Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid-positive and amyloid-negative groups from Japanese trial-ready cohort study.

Saki Nakashima, Kenichiro Sato, Yoshiki Niimi

|Dec 22, 2025
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia.

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara

|Oct 20, 2025
Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers.

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara

Pageof 3

Frequent Collaborators

4 joint publications

Yoshiki Niimi

3 joint publications

Atsushi Iwata

1 joint publications

Ryoko Ihara

1 joint publications

Kazushi Suzuki